MedPath

A One-Week Crossover Dispensing Evaluation of New Daily Wear Soft Contact Lenses

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Test Contact Lens
Device: Nelfilcon A
Registration Number
NCT03306641
Lead Sponsor
Coopervision, Inc.
Brief Summary

The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period 1 week compared to nelfilcon A (control).

Detailed Description

The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period of 1 week compared to nelfilcon A (control). The primary outcomes of interest is lens fit acceptance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Is at least 18 years of age and has full legal capacity to volunteer.
  • Is no greater than 55 years of age.
  • Has read and understood the information consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is an adapted soft contact lens wearer having worn lenses for a minimum of 4 weeks prior to the study.
  • Has spectacle cylinder ≤1.00D in both eyes.
  • Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes.
  • Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye.
  • Wears CLs in both eyes (monvision acceptable, but not monofit)
  • Has clear corneas and no active ocular disease.
  • Has not worn lenses for at least 12 hours before the examination.
  • Is willing to wear the study contact lenses for a minimum 8 hours per day/6 days per week
Exclusion Criteria
  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has strabismus/amblyopia.
  • Has undergone corneal refractive surgery.
  • Is pregnant, lactating or planning a pregnancy.
  • Is participating in any concurrent clinical or research study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Test Contact LensNelfilcon APer randomized schedule, subject will wear a pair of the test lens or control lens for one week and then cross-over with the control pair for 1 week.
nelfilcon A lens (control)Nelfilcon APer randomized schedule, subject will wear a pair of the control lens for one week and then cross-over with the test pair for 1 week.
Test Contact LensTest Contact LensPer randomized schedule, subject will wear a pair of the test lens or control lens for one week and then cross-over with the control pair for 1 week.
nelfilcon A lens (control)Test Contact LensPer randomized schedule, subject will wear a pair of the control lens for one week and then cross-over with the test pair for 1 week.
Primary Outcome Measures
NameTimeMethod
Lens Fit Acceptance1-Week

Overall lens fit acceptance was measured on a scale of 0-4 in 0.25 steps (0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University

🇺🇸

Bloomington, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath